Conversely, Del Ben et al. [132] reported that the PNPLA3 I148M gene variant was associated with a lower prevalence of MetS and reduced cardio-metabolic risk in adult subjects with hepatic steatosis. This evidence concerns the gene PNPLA3 and Hepatic steatosis.